BREVIBLOC is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Esmolol Hydrochloride.
Product ID | 10019-668_29f9b6ee-1374-4ba1-9095-e35fb6e67a2e |
NDC | 10019-668 |
Product Type | Human Prescription Drug |
Proprietary Name | BREVIBLOC |
Generic Name | Esmolol Hydrochloride |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 1986-12-31 |
Marketing Category | NDA / NDA |
Application Number | NDA019386 |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | ESMOLOL HYDROCHLORIDE |
Active Ingredient Strength | 20 mg/mL |
Pharm Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2018-01-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019386 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2018-01-31 |
Ingredient | Strength |
---|---|
ESMOLOL HYDROCHLORIDE | 20 mg/mL |
SPL SET ID: | 220a07b8-5c68-41a3-8705-fd91f14c50b4 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0404-9825 | Brevibloc | esmolol hydrochloride |
10019-055 | Brevibloc | Esmolol Hydrochloride |
10019-075 | Brevibloc | Esmolol Hydrochloride |
10019-115 | Brevibloc | Esmolol Hydrochloride |
10019-666 | BREVIBLOC | esmolol hydrochloride |
10019-668 | BREVIBLOC | esmolol hydrochloride |
10019-672 | BREVIBLOC | BREVIBLOC |
10019-670 | BREVIBLOC | BREVIBLOC |
52584-115 | Brevibloc | Brevibloc |
0404-9858 | ESMOLOL HYDROCHLORIDE | ESMOLOL HYDROCHLORIDE |
0641-2965 | Esmolol Hydrochloride | ESMOLOL HYDROCHLORIDE |
10019-120 | Esmolol Hydrochloride | Esmolol Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BREVIBLOC 73433960 1287620 Live/Registered |
American Hospital Supply Corporation 1983-07-08 |